600812 North China Pharmaceutical Company Ltd. SSE · China

North China Pharmaceutical Company (600812) news

North China Pharmaceutical Company Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600812, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest North China Pharmaceutical Company news

We have not published a story on North China Pharmaceutical Company yet. When there is news, it will appear here.

Questions about North China Pharmaceutical Company

What is the ticker symbol of North China Pharmaceutical Company?

North China Pharmaceutical Company Ltd. trades under the ticker 600812 on SSE.

Where is North China Pharmaceutical Company listed?

North China Pharmaceutical Company Ltd. is listed on SSE.

Which country or territory is North China Pharmaceutical Company listed under?

Our directory records North China Pharmaceutical Company Ltd. under China.

What does North China Pharmaceutical Company do?

Our directory classifies North China Pharmaceutical Company Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of North China Pharmaceutical Company?

The ISIN recorded for North China Pharmaceutical Company Ltd. is CNE000000D16.

Does aibio.space cover North China Pharmaceutical Company?

aibio.space lists North China Pharmaceutical Company Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to North China Pharmaceutical Company?

Companies in our directory listed in the same country and business area as North China Pharmaceutical Company: Ningbo Menovo Pharmaceutical Co., Zhejiang Shapuaisi Pharmaceutical Co., Zhuzhou Qianjin Pharmaceutical Co., Shanghai Bao Pharmaceuticals Co, Tiansheng Pharmaceutical Group Co., Hunan Er-Kang Pharmaceutical Co..

Investor discussion: North China Pharmaceutical Company

Members talk about North China Pharmaceutical Company (600812). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600812 on TradingView.

Listing details

Company: North China Pharmaceutical Company Ltd.
Ticker: 600812
Listing: SSE
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: CNE000000D16
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction